MX2014007556A - Metodos de diagnostico. - Google Patents

Metodos de diagnostico.

Info

Publication number
MX2014007556A
MX2014007556A MX2014007556A MX2014007556A MX2014007556A MX 2014007556 A MX2014007556 A MX 2014007556A MX 2014007556 A MX2014007556 A MX 2014007556A MX 2014007556 A MX2014007556 A MX 2014007556A MX 2014007556 A MX2014007556 A MX 2014007556A
Authority
MX
Mexico
Prior art keywords
diagnostic methods
methods
mammal
identifying
enamel erosion
Prior art date
Application number
MX2014007556A
Other languages
English (en)
Other versions
MX349984B (es
Inventor
Lynette Zaidel
Steven Miller
Guy Carpenter
Gordon Proctor
David Bartlett
Rebecca Moazzez
Original Assignee
Colgate Palmolive Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Colgate Palmolive Co filed Critical Colgate Palmolive Co
Publication of MX2014007556A publication Critical patent/MX2014007556A/es
Publication of MX349984B publication Critical patent/MX349984B/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4721—Cationic antimicrobial peptides, e.g. defensins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4725—Mucins, e.g. human intestinal mucin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/988—Lyases (4.), e.g. aldolases, heparinase, enolases, fumarase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/18—Dental and oral disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Se describen métodos para identificar un mamífero que presenta una susceptibilidad incrementada a la erosión del esmalte. Conjuntos de elementos, usos y otros métodos basados en ellos.
MX2014007556A 2011-12-20 2011-12-20 Metodos de diagnostico. MX349984B (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2011/066078 WO2013095367A1 (en) 2011-12-20 2011-12-20 Diagnostic methods

Publications (2)

Publication Number Publication Date
MX2014007556A true MX2014007556A (es) 2014-08-01
MX349984B MX349984B (es) 2017-08-23

Family

ID=45507887

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014007556A MX349984B (es) 2011-12-20 2011-12-20 Metodos de diagnostico.

Country Status (15)

Country Link
US (1) US9140708B2 (es)
EP (1) EP2795334B1 (es)
JP (1) JP2015507183A (es)
CN (1) CN103998936B (es)
AR (1) AR089309A1 (es)
AU (1) AU2011383728B2 (es)
BR (1) BR112014015040A2 (es)
CA (1) CA2858318A1 (es)
MX (1) MX349984B (es)
PH (1) PH12014501326A1 (es)
RU (1) RU2014129587A (es)
SG (1) SG11201402850YA (es)
TW (1) TWI471564B (es)
WO (1) WO2013095367A1 (es)
ZA (1) ZA201404276B (es)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7387774B2 (en) * 1999-11-12 2008-06-17 The Procter & Gamble Co. Method of enhancing fluoridation and mineralization of teeth
US6685920B2 (en) * 1999-11-12 2004-02-03 The Procter & Gamble Company Method of protecting teeth against erosion
WO2004089187A2 (en) * 2003-04-01 2004-10-21 University Of Southern California Caries risk test for predicting and assessing the risk of disease
JP2005331341A (ja) * 2004-05-19 2005-12-02 Horiba Ltd 口腔内健康維持能力の評価方法および評価装置
JP2007322124A (ja) * 2004-08-18 2007-12-13 Univ Nihon う蝕性リスクの判定方法及び判定薬
JP4426500B2 (ja) * 2005-04-28 2010-03-03 猛志 奥 歯のう蝕罹患リスクの評価方法及び装置並びにプログラム
EP2114989B1 (en) 2007-01-16 2016-04-06 Rutgers, the State University of New Jersey Natural polypeptides for oral health care

Also Published As

Publication number Publication date
PH12014501326A1 (en) 2014-10-20
AU2011383728A1 (en) 2014-06-19
ZA201404276B (en) 2016-03-30
CN103998936A (zh) 2014-08-20
EP2795334A1 (en) 2014-10-29
US20140348762A1 (en) 2014-11-27
CN103998936B (zh) 2016-03-23
RU2014129587A (ru) 2016-02-20
US9140708B2 (en) 2015-09-22
MX349984B (es) 2017-08-23
SG11201402850YA (en) 2014-10-30
TWI471564B (zh) 2015-02-01
TW201331584A (zh) 2013-08-01
AU2011383728B2 (en) 2014-09-04
CA2858318A1 (en) 2013-06-27
WO2013095367A1 (en) 2013-06-27
EP2795334B1 (en) 2016-09-28
BR112014015040A2 (pt) 2017-06-13
AR089309A1 (es) 2014-08-13
JP2015507183A (ja) 2015-03-05

Similar Documents

Publication Publication Date Title
IL257330B (en) Preparations, methods and kits for diagnosing lung cancer
GB2487632B (en) Methods,compositions,and kits for determining the presence/absence of a variant nucleic acid sequence
MX340453B (es) Biomarcadores para cancer de pulmon.
GB2522366A (en) Mapping cytosine modifications
IN2014CN02283A (es)
PH12014501108A1 (en) Anti-il-36r antibodies
GB201321365D0 (en) Methods for performing patterned chemistry
IN2012DE02913A (es)
EP2780465A4 (en) METHOD, DEVICES AND KITS FOR OBTAINING AND ANALYZING CELLS
EP2668590A4 (en) Identifying categorized misplacement
WO2012135340A3 (en) Compositions and methods for diagnosing cancer
IN2015DN01166A (es)
EP2694667A4 (en) METHOD, COMPOSITIONS AND KITS FOR TESTING THE MITOCHONDRY FUNCTION
BR112013032555A2 (pt) composição selante híbrida
HK1204061A1 (en) Methods and kits for detecting and diagnosing neurotrauma
IN2014DN03298A (es)
EP2638178A4 (en) COMPOSITIONS, METHODS, AND KITS FOR DETECTING AND IDENTIFYING MYCOBACTERIES
IL228006A0 (en) Endodontic instruments, kits and methods for using endodontic instruments
EP2742358A4 (en) METHOD FOR THE DIAGNOSIS OF CANCER
UY34286A (es) Diagnóstico de vacuna mejorado
IN2012DE02933A (es)
IN2012DE02272A (es)
WO2012103424A9 (en) Diagnostic and prognostic markers for metastasis
MX349984B (es) Metodos de diagnostico.
EP2661625A4 (en) DIAGNOSTIC PROCEDURE

Legal Events

Date Code Title Description
FG Grant or registration